6-month drug regimen cuts HIV risk for breastfeeding infants

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.

Read the whole article on Physorg

More from Physorg